Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (239) 239
Publication (49) 49
Book / eBook (8) 8
Newspaper Article (8) 8
Book Chapter (6) 6
Book Review (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (130) 130
index medicus (109) 109
male (93) 93
infectious diseases (87) 87
adult (82) 82
hiv (81) 81
female (76) 76
middle aged (69) 69
hiv infections - drug therapy (58) 58
immunology (47) 47
human immunodeficiency virus--hiv (42) 42
risk factors (39) 39
antiretroviral therapy (37) 37
hiv infection (37) 37
mortality (31) 31
aids (30) 30
antiviral agents (30) 30
hiv infections - complications (29) 29
health aspects (28) 28
article (27) 27
infection (27) 27
virology (27) 27
antiretroviral drugs (26) 26
australia (26) 26
drug therapy (26) 26
medicine, general & internal (26) 26
research (26) 26
therapy (26) 26
aged (25) 25
infections (24) 24
abridged index medicus (23) 23
acquired immune deficiency syndrome--aids (22) 22
analysis (22) 22
anti-hiv agents - therapeutic use (22) 22
aids/hiv (21) 21
incidence (21) 21
risk (21) 21
care and treatment (20) 20
cd4 lymphocyte count (20) 20
prevalence (20) 20
adolescent (19) 19
young adult (19) 19
medical and health sciences (18) 18
medicin och hälsovetenskap (18) 18
prevention (18) 18
public, environmental & occupational health (18) 18
studies (18) 18
viral load (18) 18
adults (17) 17
disease (17) 17
treatment outcome (17) 17
diagnosis (16) 16
drug therapy, combination (16) 16
human immunodeficiency virus (16) 16
human-immunodeficiency-virus (16) 16
usage (16) 16
antiretroviral agents (15) 15
cohort studies (15) 15
health risks (15) 15
hiv infections - epidemiology (15) 15
hiv patients (15) 15
medical research (15) 15
medicine (15) 15
microbiology (15) 15
population (15) 15
public health (15) 15
epidemiology (14) 14
infected patients (14) 14
research article (14) 14
animals (13) 13
cardiovascular disease (13) 13
clinical trials (13) 13
dosage and administration (13) 13
hiv infections - virology (13) 13
retrospective studies (13) 13
sex (13) 13
tenofovir (13) 13
time factors (13) 13
aged, 80 and over (12) 12
anti-hiv agents - adverse effects (12) 12
cardiovascular diseases (12) 12
highly active antiretroviral therapy (12) 12
hiv infections - immunology (12) 12
age (11) 11
child (11) 11
clinical medicine (11) 11
follow-up studies (11) 11
global health (11) 11
health (11) 11
internal medicine (11) 11
klinisk medicin (11) 11
life expectancy (11) 11
patients (11) 11
pharmacology & pharmacy (11) 11
sexually transmitted diseases (11) 11
acquired immune deficiency syndrome (10) 10
anti-hiv agents - administration & dosage (10) 10
antiretroviral therapy, highly active (10) 10
australia - epidemiology (10) 10
cardiovascular-disease (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
University College (Laidlaw) - Stacks (2) 2
Art - Library use only (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Richard Charles Lee Canada-Hong Kong - Library use only (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Thomas Fisher Rare Book - May be requested at Fisher (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Switch from tenofovir DF to raltegravir is not associated with weight gain over 96 weeks
by Carr, Mirella and Richardson, Robyn and Tong, Winnie and Bloch, Mark and Baker, David and Hoy, Jennifer F and TROP study team
AIDS, ISSN 0269-9370, 12/2019, p. 1
Integrase inhibitor-based antiretroviral therapy (INSTI-ART) can cause weight gain. It is unknown if this is a class effect, with limited data regarding... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Monocytes from men living with HIV exhibit heightened atherogenic potential despite long term viral suppression with ART
by Angelovich, Thomas A and Trevillyan, Janine M and Hoy, Jennifer F and Wong, Michelle E and Agius, Paul A and Hearps, Anna C and Jaworowski, Anthony
AIDS, ISSN 0269-9370, 12/2019, p. 1
OBJECTIVE:People living with HIV have an increased risk of cardiovascular disease (CVD) despite effective antiretroviral therapy (ART). Monocytes play a key... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
by Jaworowski, A and Hearps, AC and Angelovich, TA and Hoy, JF
FRONTIERS IN IMMUNOLOGY, ISSN 1664-3224, 06/2019, Volume 10, p. 1378
Combination antiretroviral therapy (ART) is effective at suppressing HIV viremia to achieve persistently undetectable levels in peripheral blood in the... 
atherosclerosis | METABOLIC SYNDROME | monocytes/macrophages | MYOCARDIAL-INFARCTION | LOW-DENSITY-LIPOPROTEIN | SUBCLINICAL ATHEROSCLEROSIS | IMMUNOLOGY | INNATE IMMUNE ACTIVATION | DIABETES-MELLITUS | CIGARETTE-SMOKING | HIV | inflammation | FOAM CELL-FORMATION | AGE-RELATED-CHANGES | foam cells/macrophages | INFECTED PATIENTS | Highly active antiretroviral therapy | HIV patients | Usage | Health aspects | Risk factors | Atherosclerosis | Diagnosis | Drug therapy | HIV infection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Zoledronic acid is superior to tenofovir DF-switching for low bone mineral density in adults with HIV: a randomised trial
by Hoy, Jennifer F and Richardson, Robyn and Ebeling, Peter R and Rojas, Jhon and Pocock, Nicholas and Kerr, Stephen J and Martinez, Esteban and Carr, Andrew
AIDS, ISSN 0269-9370, 06/2018, p. 1
OBJECTIVE:To compare the effects of switching tenofovir disoproxil fumarate (TDF) or treatment with an intravenous bisphosphonate on bone mineral density (BMD)... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy
by Smibert, Olivia C and Trubiano, Jason A and Cross, Gail B and Hoy, Jennifer F
AIDS Research and Human Retroviruses, ISSN 0889-2229, 12/2017, Volume 33, Issue 12, pp. 122 - 1204
A 10-year review of disseminated Mycobacterium avium complex (MAC) infection and MAC–immune reconstitution inflammatory syndrome in HIV-positive patients... 
Pathogenesis | IRIS | immune reconstitution | Mycobacterium avium complex | HIV | antiretroviral therapy | MAC | INFECTIOUS DISEASES | VIROLOGY | IMMUNOLOGY | Antiretroviral drugs | Therapy | Antiretroviral agents | Human immunodeficiency virus--HIV | Immune reconstitution | Infections | Inflammation | Drug therapy | Antiretroviral therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV
by Hoy, JF and Richardson, R and Ebeling, PR and Rojas, J and Pocock, N and Kerr, SJ and Martinez, E and Carr, A and ZEST Study Investigators
AIDS, ISSN 0269-9370, 09/2018, Volume 32, Issue 14, pp. 1967 - 1975
Objective: To compare the effects of switching tenofovir disoproxil fumarate (TDF) or treatment with an intravenous bisphosphonate on bone mineral density... 
VITAMIN-D | INFECTIOUS DISEASES | ABACAVIR-LAMIVUDINE | tenofovir | EMTRICITABINE | ANTIRETROVIRAL THERAPY | OPEN-LABEL | IMMUNOLOGY | osteoporosis | ALENDRONATE | bone mineral density | FRACTURE | VIROLOGY | HIV | zoledronic acid | MEN | INFECTED PATIENTS | POSTMENOPAUSAL WOMEN | Tenofovir | Zoledronic acid | HIV patients | Dosage and administration | Drug therapy | Osteopenia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text No adverse safety or virological changes two years following vorinostat in HIV-infected individuals on antiretroviral therapy
by MOTA, Talia M and RASMUSSEN, Thomas A and RHODES, Ajantha and TENNAKOON, Surekha and DANTANARAYANA, Ashanti and WIGHTMAN, Fiona and HAGENAUER, Michelle and RONEY, Janine and SPELMAN, Tim and PURCELL, Damian FJ and McMAHON, James and HOY, Jennifer F and PRINCE, H. Miles and ELLIOTT, Julian H and LEWIN, Sharon R
AIDS (London, England), ISSN 0269-9370, 5/2017, Volume 31, Issue 8, pp. 1137 - 1141
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Antiretroviral Treatment of Adult HIV Infection: 2014 Recommendations of the International Antiviral Society–USA Panel
by Günthard, Huldrych F and Aberg, Judith A and Eron, Joseph J and Hoy, Jennifer F and Telenti, Amalio and Benson, Constance A and Burger, David M and Cahn, Pedro and Gallant, Joel E and Glesby, Marshall J and Reiss, Peter and Saag, Michael S and Thomas, David L and Jacobsen, Donna M and Volberding, Paul A and International Antiviral Society-USA Panel
JAMA, ISSN 0098-7484, 07/2014, Volume 312, Issue 4, pp. 410 - 425
IMPORTANCE: New data and antiretroviral regimens expand treatment choices in resource-rich settings and warrant an update of recommendations to treat adults... 
LOW-LEVEL VIREMIA | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | TWICE-DAILY RALTEGRAVIR | REVERSE-TRANSCRIPTASE INHIBITORS | ONCE-DAILY DOLUTEGRAVIR | TREATMENT-EXPERIENCED PATIENTS | CO-FORMULATED ELVITEGRAVIR | DOUBLE-BLIND | ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | BOOSTED PROTEASE INHIBITOR | Anti-HIV Agents - administration & dosage | Drug Costs | Anti-HIV Agents - adverse effects | HIV Infections - diagnosis | Humans | Treatment Failure | Drug Resistance, Viral | Adult | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | CD4 Lymphocyte Count | Drug Therapy, Combination | Antiretroviral drugs | Adults | Human immunodeficiency virus--HIV | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel
by Thompson, Melanie A and Aberg, Judith A and Hoy, Jennifer F and Telenti, Amalio and Benson, Constance and Cahn, Pedro and Eron, Joseph J and Günthard, Huldrych F and Hammer, Scott M and Reiss, Peter and Richman, Douglas D and Rizzardini, Giuliano and Thomas, David L and Jacobsen, Donna M and Volberding, Paul A
JAMA, ISSN 0098-7484, 07/2012, Volume 308, Issue 4, pp. 387 - 402
CONTEXT New trial data and drug regimens that have become available in the last 2 years warrant an update to guidelines for antiretroviral therapy (ART) in... 
LOW-LEVEL VIREMIA | MEDICINE, GENERAL & INTERNAL | TWICE-DAILY RALTEGRAVIR | ABACAVIR-LAMIVUDINE | VIRUS-INFECTION | MYOCARDIAL-INFARCTION | CLINICAL-TRIALS | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | PHARMACOKINETIC INTERACTIONS | HEPATITIS-C | AIDS-Related Opportunistic Infections | Drug Administration Schedule | Humans | Anti-Retroviral Agents - adverse effects | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Hepatitis B - complications | Pregnancy | Medication Adherence | Societies, Medical | Anti-Retroviral Agents - administration & dosage | Treatment Failure | HIV Infections - complications | Pregnancy Complications, Infectious - drug therapy | Adult | Female | HIV Infections - drug therapy | Hepatitis C - complications | Drug Therapy, Combination | Quality of Health Care | Antiretroviral drugs | Medical research | Human immunodeficiency virus--HIV | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Dolutegravir monotherapy as maintenance ART bites the dust
by Trevillyan, Janine M and Hoy, Jennifer F
The Lancet HIV, ISSN 2352-3018, 12/2017, Volume 4, Issue 12, pp. e531 - e532
INDIVIDUALS | TRIAL | INFECTIOUS DISEASES | HIV RNA | EFFICACY | SAFETY | DARUNAVIR/RITONAVIR MONOTHERAPY | VIRAL SUPPRESSION | COPIES/ML | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | Heterocyclic Compounds, 3-Ring | HIV Infections - drug therapy | Humans | HIV Integrase Inhibitors - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial
: GREATER BMD LOSS WITH IMMEDIATE VERSUS DEFERRED ART
by Hoy, Jennifer F and Grund, Birgit and Roediger, Mollie and Schwartz, Ann V and Shepherd, John and Avihingsanon, Anchalee and Badal-Faesen, Sharlaa and de Wit, Stephane and Jacoby, Simone and La Rosa, Alberto and Pujari, Sanjay and Schechter, Mauro and White, David and Engen, Nicole Wyman and Ensrud, Kristine and Aagaard, Peer D and Carr, Andrew and for the INSIGHT START Bone Mineral Density Substudy Group
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2017, Volume 32, Issue 9, pp. 1945 - 1955
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel
by Saag, Michael S and Benson, Constance A and Gandhi, Rajesh T and Hoy, Jennifer F and Landovitz, Raphael J and Mugavero, Michael J and Sax, Paul E and Smith, Davey M and Thompson, Melanie A and Buchbinder, Susan P and Del Rio, Carlos and Eron, Joseph J and Fätkenheuer, Gerd and Günthard, Huldrych F and Molina, Jean-Michel and Jacobsen, Donna M and Volberding, Paul A
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 07/2018, Volume 320, Issue 4, pp. 379 - 396
IMPORTANCE Antiretroviral therapy (ART) is the cornerstone of prevention and management of HIV infection. OBJECTIVE To evaluate new data and treatments and... 
MULTIDRUG-RESISTANT HIV-1 | NON-INFERIORITY | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | VIROLOGICALLY SUPPRESSED ADULTS | COST-EFFECTIVENESS | DEMAND PREEXPOSURE PROPHYLAXIS | ATAZANAVIR/RITONAVIR PLUS LAMIVUDINE | DOUBLE-BLIND | HUMAN-IMMUNODEFICIENCY-VIRUS | CD4 CELL COUNT | HIV Infections - prevention & control | Anti-Retroviral Agents - therapeutic use | Diagnosis, Differential | Time-to-Treatment | HIV Infections - diagnosis | Humans | Adult | HIV Infections - drug therapy | Fees, Pharmaceutical | Advisory Committees | Prevention | Antiviral agents | Treatment outcome | Analysis | Adults | Dosage and administration | Drug therapy | Health aspects | HIV infection | Drugs | Therapy | RNA-directed DNA polymerase | Prophylaxis | Medical services | Risk | Infections | Drug resistance | Tenofovir | Literature reviews | Sexually transmitted diseases | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Genotypes | Monitoring | Integrase | Emtricitabine | Antiretroviral drugs | Medical treatment | Health risks | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Disease prevention | Pregnancy | Laboratory tests | Risk management
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel
by Günthard, Huldrych F and Saag, Michael S and Benson, Constance A and del Rio, Carlos and Eron, Joseph J and Gallant, Joel E and Hoy, Jennifer F and Mugavero, Michael J and Sax, Paul E and Thompson, Melanie A and Gandhi, Rajesh T and Landovitz, Raphael J and Smith, Davey M and Jacobsen, Donna M and Volberding, Paul A
JAMA, ISSN 0098-7484, 07/2016, Volume 316, Issue 2, pp. 191 - 210
IMPORTANCE: New data and therapeutic options warrant updated recommendations for the use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in... 
LOW-LEVEL VIREMIA | MEDICINE, GENERAL & INTERNAL | TENOFOVIR DISOPROXIL FUMARATE | VIROLOGICALLY SUPPRESSED ADULTS | TWICE-DAILY RALTEGRAVIR | REVERSE-TRANSCRIPTASE INHIBITORS | ONCE-DAILY DOLUTEGRAVIR | RITONAVIR PLUS LAMIVUDINE | COGNITIVE-BEHAVIORAL THERAPY | DEPRESSION CBT-AD | BOOSTED PROTEASE INHIBITOR | HIV-1 | HIV Infections - prevention & control | AIDS-Related Opportunistic Infections | Anti-Retroviral Agents - therapeutic use | Prognosis | Viremia | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Viral Load | Pre-Exposure Prophylaxis | Pregnancy | Young Adult | Treatment Failure | Adolescent | Post-Exposure Prophylaxis | Adult | Female | HIV Infections - drug therapy | Aged | Drug Therapy, Combination | Prevention | Antiviral agents | Care and treatment | Dosage and administration | HIV infection | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Management guidelines for non-AIDS morbidity result in increased screening but no change in primary prevention implementation
by Trevillyan, Janine M and Trevillyan, Janine M and Dart, Anthony and Dart, Anthony and Topliss, Duncan J and Topliss, Duncan J and Walker, Rowan G and Walker, Rowan G and Whiting, Sarah E and Whiting, Sarah E and Hoy, Jennifer F and Hoy, Jennifer F
AIDS (London, England), ISSN 0269-9370, 03/2015, Volume 29, Issue 6, pp. 748 - 750
INFECTIOUS DISEASES | HIV-INFECTION | VIROLOGY | IMMUNOLOGY | Cardiovascular Diseases - epidemiology | Female | Male | Humans | HIV Infections - complications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
by Elliott, Julian H and Wightman, Fiona and Solomon, Ajantha and Ghneim, Khader and Ahlers, Jeffrey and Cameron, Mark J and Smith, Miranda Z and Spelman, Tim and McMahon, James and Velayudham, Pushparaj and Brown, Gregor and Roney, Janine and Watson, Jo and Prince, Miles H and Hoy, Jennifer F and Chomont, Nicolas and Fromentin, Rémi and Procopio, Francesco A and Zeidan, Joumana and Palmer, Sarah and Odevall, Lina and Johnstone, Ricky W and Martin, Ben P and Sinclair, Elizabeth and Deeks, Steven G and Hazuda, Daria J and Cameron, Paul U and Sékaly, Rafick-Pierre and Lewin, Sharon R
PLoS Pathogens, ISSN 1553-7366, 11/2014, Volume 10, Issue 11, p. e1004473
Human immunodeficiency virus (HIV) persistence in latently infected resting memory CD4+ T-cells is the major barrier to HIV cure. Cellular histone deacetylases... 
RNA | CD4(+) T-CELLS | MICROBIOLOGY | REPLICATION | VIROLOGY | MODELS | IN-VIVO | IMMUNE ACTIVATION | LATENCY | HISTONE DEACETYLASE INHIBITORS | TYPE-1 | EXPRESSION | PARASITOLOGY | Transcription, Genetic - drug effects | HIV-1 - drug effects | HIV Infections - virology | Humans | Middle Aged | Male | Virus Latency - drug effects | CD4-Positive T-Lymphocytes - immunology | HIV Infections - immunology | HIV-1 - immunology | HIV-1 - physiology | RNA, Viral - genetics | Virus Activation - drug effects | Lymphocyte Activation - drug effects | Adult | Female | HIV Infections - drug therapy | Hydroxamic Acids - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | CD4-Positive T-Lymphocytes - virology | Antiviral agents | Genetic research | HIV patients | Dosage and administration | Genetic aspects | Genetic transcription | Research | Drug therapy | Virus research | Antiretroviral drugs | AIDS | Human immunodeficiency virus | HIV | Acquired immune deficiency syndrome | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Outcomes following detection of low level plasma HIV RNA in HIV-infected patients previously virologically suppressed on antiretroviral therapy: A retrospective observational study
by Warren, Annabelle M and Cheng, Allen C and Watson, Kerrie and Lewin, Sharon R and Hoy, Jennifer F
Sexual Health, ISSN 1448-5028, 2017, Volume 14, Issue 3, pp. 238 - 243
Background: Progressively sensitive assays for plasma HIV RNA have led to increased detection of plasma HIV RNA between 20 and 200 copies/ml, known as low... 
HIV/AIDS | surveillance | low level viremia | VIRAL LOAD | INFECTIOUS DISEASES | TRANSIENT VIREMIA | BLIPS | HIV-1-INFECTED PATIENTS | DRUG-RESISTANCE | TREATED PATIENTS | FAILURE | RESIDUAL VIREMIA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | T-CELL-ACTIVATION | HAART | Antiretroviral drugs | Therapy | Viremia | Diabetes mellitus | Management | Criteria | Multivariate analysis | Drug resistance | Assaying | Ribonucleic acid--RNA | Patients | Low level | Data bases | Antiretroviral therapy | CD4 antigen | Databases | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Age
Journal Article
Details down arrow